Epigenetic events underlie the pathogenesis of sinonasal papillomas

Modern Pathology

Volumn 20, Issue 10, 2007, Pages 1019-1027

  Stephen, Josena K ^a   Vaught, Lori E ^a   Chen, Kang M ^a   Sethi, Seema ^a   Shah, Veena ^a   Benninger, Michael S ^a   Gardner, Glendon M ^a   Schweitzer, Vanessa G ^a   Khan, Mumtaz ^a   Worsham, Maria J ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Epigenetics; Inverted papillomas; Methylation specific multiplex ligation specific polymerase assay; Methylation specific PCR; Promoter hypermethylation; Sinonasal papillomas

Indexed keywords

APC PROTEIN; BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 2B; DEATH ASSOCIATED PROTEIN KINASE; DNA; FANCONI ANEMIA GROUP D2 PROTEIN; FORMALDEHYDE; GLUTATHIONE TRANSFERASE P1; PROTEIN MLH1; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ARTICLE; CLINICAL ARTICLE; DNA METHYLATION; EPIGENETICS; GENE PROBE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; INVERTED PAPILLOMA; MICRODISSECTION; NOSE POLYP; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SINONASAL PAPILLOMA; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY;

COHORT STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DNA METHYLATION; DNA, NEOPLASM; GENE SILENCING; HUMANS; MICRODISSECTION; NEOPLASM RECURRENCE, LOCAL; PAPILLOMA; PARANASAL SINUS NEOPLASMS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS);

EID: 34548720420     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800944     Document Type: Article

References (47)

1. Hyams VJ. Papillomas of the nasal cavity and paranasal sinuses. A clinicopathological study of 315 cases. Ann Otol Rhinol Laryngol 1971;80:192-206.
2. Batsakis JG, Suarez P. Schneiderian papillomas and carcinomas: a review. Adv Anat Pathol 2001;8:53-64.
3. Wormald PJ, Ooi E, van Hasselt CA, et al. Endoscopic removal of sinonasal inverted papilloma including endoscopic medial maxillectomy. Laryngoscope 2003;113:867-873.
4. Califano J, Koch W, Sidransky D, et al. Inverted sinonasal papilloma: a molecular genetic appraisal of its putative status as a Precursor to squamous cell carcinoma. Am J Pathol 2000;156:333-337.
5. Buchwald C, Franzmann MB, Jacobsen GK, et al. Human papillomavirus (HPV) in sinonasal papillomas: a study of 78 cases using in situ hybridization and polymerase chain reaction. Laryngoscope 1995;105:66-71.
6. Brandwein M, Steinberg B, Thung S, et al. Human papillomavirus 6/11 and 16/18 in Schneiderian inverted papillomas. In situ hybridization with human papillomavirus RNA probes. Cancer 1989;63:1708-1713.
7. Buchwald C, Lindeberg H, Pedersen BL, et al. Human papilloma virus and p53 expression in carcinomas associated with sinonasal papillomas: a Danish Epidemiological study 1980-1998. Laryngoscope 2001;111:1104-1110.
8. Syrjanen KJ. HPV infections in benign and malignant sinonasal lesions. J Clin Pathol 2003;56:174-181.
9. Syrjanen S, Happonen RP, Virolainen E, et al. Detection of human papillomavirus (HPV) structural antigens and DNA types in inverted papillomas and squamous cell carcinomas of the nasal cavities and paranasal sinuses. Acta Otolaryngol 1987;104:334-341.
10. Katori H, Nozawa A, Tsukuda M. Markers of malignant transformation of sinonasal inverted papilloma. Eur J Surg Oncol 2005;31:905-911.
11. Herman JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995;55:4525-4530.
12. Worsham MJ, Chen KM, Meduri V, et al. Epigenetic events of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2006;132:668-677.
13. Raju ULM, Sethi S, Qureshi H, et al. Molecular classification of breast carcinoma in situ. Current Genomics 2006;7:523-532.
14. Worsham MJ, Pals G, Schouten JP et al. Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2003;129:702-708.
15. Worsham MJ, Pals G, Schouten JP, et al. High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model. Breast Cancer Res Treat 2006;96:177-186.
16. Worsham MJ, Chen KM, Tiwari N, et al. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a) and MTAP genes in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2006;132:409-415.
17. Kunjoonju JP, Raitanen M, Grenman S, et al. Identification of individual genes altered in squamous cell carcinoma of the vulva. Genes Chromosomes Cancer 2005;44:185-193.
18. Nygren AO, Ameziane N, Duarte HM, et al. Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res 2005;33:e128.
19. Worsham MJ, Chen KM, Sawheny R, et al. Methylation of multiple genes as diagnostic and therapeutic markers in primary HNSCC. Arch Otolaryngol Head Neck Surg (in press).
20. Stephen JK, Vaught LE, Chen KM, et al. An epigenetically derived monoclonal origin for recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 2007;133:684-692.
21. Lawson W, Kaufman MR, Biller HF. Treatment outcomes in the management of inverted papilloma: an analysis of 160 cases. Laryngoscope 2003;113:1548-1556.
22. Lawson W, Ho BT, Shaari CM et al. Inverted papilloma: a report of 112 cases. Laryngoscope 1995;105:282-288.
23. Gujrathi C, Pathak I, Freeman J, et al. Expression of p53 in inverted papilloma and malignancy associated with inverted papilloma. J Otolaryngol 2003;32:48-50.
24. el-Deiry WS. p21/p53, cellular growth control and genomic integrity. Curr Top Microbiol Immunol 1998;227:121-137.
25. Yook JI, Kim J. Expression of p21WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas. Oral Oncol 1998;34:198-203.
26. Ng IO, Lam KY, Ng M, et al. Expression of p21/waf1 in oral squamous cell carcinomas - correlation with p53 and mdm2 and cellular proliferation index. Oral Oncol 1999;35:63-69.
27. Baylin SB, Herman JG, Graff JR, et al. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998;72:141-196.
28. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999;21:163-167.
29. Kim TY, Lee HJ, Hwang KS, et al. Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab Invest 2004;84:479-484.
30. Danahey DG, Tobin EJ, Schuller DE, et al. p16 mutation frequency and clinical correlation in head and neck cancer. Acta Otolaryngol 1999;119:285-288.
31. Lydiatt WM, Davidson BJ, Schantz SP, et al. 9p21 deletion correlates with recurrence in head and neck cancer. Head Neck 1998;20:113-118.
32. Sherr CJ. Cancer cell cycles. Science 1996;274:1672-1677.
33. Xing EP, Nie Y, Song Y, et al. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res 1999;5:2704-2713.
34. Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 1994;371:257-261.
35. Shintani S, Nakahara Y, Mihara M, et al. Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas. Oral Oncol 2001;37:498-504.
36. Yeh KT, Chang JG, Lin TH, et al. Epigenetic changes of tumor suppressor genes, P15, P16, VHL and P53 in oral cancer. Oncol Rep 2003;10:659-663.
37. Wong TS, Tang KC, Kwong DL, et al. Differential gene methylation in undifferentiated nasopharyngeal carcinoma. Int J Oncol 2003;22:869-874.
38. White PS, Maris JM, Beltinger C, et al. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci USA 1995;92:5520-5524.
39. Nagai H, Negrini M, Carter SL, et al. Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer. Cancer Res 1995;55:1752-1757.
40. Weith A, Martinsson T, Cziepluch C, et al. Neuroblastoma consensus deletion maps to 1p36.1-2. Genes Chromosomes Cancer 1989;1:159-166.
41. Dong S, Pang JC, Hu J, et al. Transcriptional inactivation of TP73 expression in oligodendroglial tumors. Int J Cancer 2002;98:370-375.
42. Kaghad M, Bonnet H, Yang A, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997;90:809-819.
43. Ponglikitmongkol M, Green S, Chambon P. Genomic organization of the human oestrogen receptor gene. EMBO J 1988;7:3385-3388.
44. Garcia M, Derocq D, Freiss G, et al. Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. Proc Natl Acad Sci USA 1992;89:11538-11542.
45. Issa JP, Ottaviano YL, Celano P, et al. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994;7:536-540.
46. Eads CA, Lord RV, Kurumboor SK, et al. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res 2000;60:5021-5026.
47. Yasumatsu R, Nakashima T, Masuda M, et al. Clinical value of serum squamous cell carcinoma antigen in the management of sinonasal inverted papilloma. Head Neck 2005;27:44-48.